Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Curcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study

NCT02298985 is registered in ClinicalTrials.gov with Beersheva Mental Health Center as lead sponsor.

NCT NCT02298985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02298985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Curcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study
Lead sponsor
Beersheva Mental Health Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
May 31, 2017
Enrollment
38 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic schizophrenia